Adverse Events Following Immunization Monitoring-Covid-19 Vaccines-Lebanon-14th February 2021-June 3

Adverse Events Following Immunization Monitoring-Covid-19 Vaccines-Lebanon-14th February 2021-June 30th 2022

This report provides a summary of Adverse Events Following Immunization (AEFIs) that occurred after administration of the COVID-19 Vaccines in Lebanon during the mass campaign immunization between February 14, 2021 and June 30th, 2022.

The executive summary and the full report are available on: https://www.moph.gov.lb/en/Pages/4/44742/.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09DA01	LOSARTAN/HYDROCHLOROTHIAZIDE REMEDICA	G	Losartan potassium - 50mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	635,638 L.L
N03AX14	LEPITAM	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,336,163 L.L
J01MA14	LOXIMED	G	Moxifloxacin (HCl) - 400mg	400mg	Tablet	851,100 L.L
N03AX14	LEVETIRACETAM ARROW	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,639,488 L.L
C09DA01	LOSANET-H FORTE	G	Losartan potassium - 100mg, Hydrochlorothiazide - 12.5mg		Tablet	395,474 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01MA14	LOXIPHAR	G	Moxifloxacin (HCl) - 400mg	400mg	Tablet	1,063,555 L.L
N03AX14	LEVETRIMED	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,336,163 L.L
C09DA01	LOSARTAN/HYDROCHLOROTHIAZIDE ARROW LAB	G	Losartan potassium - 100mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	470,345 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
N03AX14	LEVIPRAM	G	Levetiracetam - 100mg/ml	100mg/ml	Solution	1,285,609 L.L
C09DA01	LOSARTAN/HYDROCHLOROTHIAZIDE BGR	G	Losartan potassium - 100mg, Hydrochlorothiazide - 25mg		Tablet, coated	439,436 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution	3,455,595 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	433,869 L.L
N03AX14	LEVIPRAM IV	G	Levetiracetam - 500mg/100ml	500mg/100ml	Injectable solution	1,869,733 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	403,153 L.L
N03AX14	LEVIPRAM IV	G	Levetiracetam - 1000mg/100ml	1000mg/100ml	Injectable solution	2,911,659 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g, Lidocaine (ampoule) -	0.5g	Injectable powder for solution+diluent	403,153 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution	3,455,595 L.L
N03AX18	LACOSAMIDE/GENEPHARM	G	Lacosamide - 50mg	50mg	Tablet	614,136 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 0.5g	0.5g	Injectable powder for solution+diluent	511,940 L.L
N03AX18	LACOSAMIDE/GENEPHARM	G	Lacosamide - 100mg	100mg	Tablet	4,856,647 L.L
L04AA27	LYXIA	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule, hard	32,406,715 L.L
R06AX13	LORADAD	G	Loratadine - 10mg	10mg	Tablet	131,697 L.L
R06AX13	LORATIN	G	Loratadine (micronised) - 10mg	10mg	Tablet	247,267 L.L
R06AX13	LORINE	G	Loratadine (micronised) - 10mg	10mg	Tablet	247,267 L.L
L04AA27	LYXIA	G	Fingolimod Hydrochloride - 0.25mg	0.5mg	Capsule, hard	32,406,715 L.L
N03AX18	LACOSAMIDE/GENEPHARM	G	Lacosamide - 200mg	200mg	Tablet	8,284,105 L.L
C10BA05	LIPONORM PLUS 10/10	G	Atorvastatin - 10mg, Ezetimibe - 10mg		Tablet	974,286 L.L

...